Other Emerging Treatment Modalities in Cutaneous Squamous Cell Carcinoma
Shared insight on novel treatment modalities in the setting of cutaneous squamous cell carcinoma and how they may be triaged moving forward.
EP: 1.Cutaneous Squamous Cell Carcinoma: Incidence and Risk Factors
EP: 2.Available Staging Systems for Cutaneous Squamous Cell Carcinoma
EP: 3.Optimal Risk Stratification in Patients With Cutaneous Squamous Cell Carcinoma
EP: 4.Defining Resectability in CSCC
EP: 5.Staging and Risk Stratification’s Impact on Treatment Approach in CSCC
EP: 6.Real World Experience With Resectable Cutaneous Squamous Cell Carcinoma
EP: 7.Evolving Treatment Paradigm of Resectable CSCC
EP: 8.Clinical Experience With Neoadjuvant IO Therapy in Melanoma
EP: 9.Lessons Learned in Other Cancers and Suggested Endpoints in Future Trials
EP: 10.Neoadjuvant IO Therapy Trials in Resectable CSCC and Cemiplimab Data Updates
EP: 11.CSCC: Translating Cemiplimab Data Into Practice
Now Viewing
EP: 12.Other Emerging Treatment Modalities in Cutaneous Squamous Cell Carcinoma
EP: 13.Best Practices in Multidisciplinary Care for CSCC
EP: 14.CSCC: Escalating Therapy for High-risk Patients
EP: 15.Practical Advice on the Evolving Management of CSCC
Related Videos
Related Content
